…
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy. The Continuing Education segment provides medical education, including residency preparation programs, specialization test preparation, graduate courses in medicine, and digital and in-person professional development for physicians and medical students. The Medical Practice Solutions segment offers clinical decision support platforms, medical practice management software, healthcare financial services, and digital healthcare ecosystem solutions, such as electronic medical records, practice management tools, telemedicine, digital prescriptions, and doctor-patient relationship platforms. This segment also provides a subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. The company also offers educational health and medical imaging; and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. In addition, it offers printed and digital content, as well as an online medical education platform and physicians, healthcare professionals and students. Afya Limited was founded in 1999 and is headquartered in Belo Horizonte, Brazil.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Afya Ltd is a Brazil-based provider of medical education and professional training offering undergraduate and postgraduate programs, residency-preparation and digital learning services to healthcare students and professionals. The company appears positioned to benefit from Brazil's physician shortfall, growing demand for continuous professional development and wider adoption of digital delivery, which may support recurring revenue and scale advantages for a specialist provider.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 844.03M | 676.39M | 429.58M | 428.43M | 273.46M |
| Minority interest | -15.98M | -17.41M | -19.90M | -19.19M | -18.96M |
| Net income | 737.68M | 631.51M | 386.32M | 373.57M | 223.33M |
| Selling general administrative | 1113.07M | 1069.32M | 1014.68M | 798.15M | 622.62M |
| Gross profit | 2336.54M | 2088.73M | 1766.10M | 1469.51M | 1067.07M |
| Reconciled depreciation | 373.34M | 333.34M | 266.69M | 206.22M | 154.22M |
| Ebit | - | 1013.91M | 815.88M | 664.10M | 440.89M |
| Ebitda | 1189.37M | 1218.02M | 1105.39M | 856.35M | 585.53M |
| Depreciation and amortization | - | 204.12M | 289.51M | 192.25M | 144.64M |
| Operating income | 1189.37M | 1012.11M | 767.06M | 664.10M | 440.89M |
| Other operating expenses | 2435.26M | 2292.22M | 2108.85M | 1665.13M | 1281.78M |
| Interest expense | 493.78M | 366.35M | 386.30M | 288.65M | 175.65M |
| Tax provision | 92.50M | 27.47M | 43.36M | 35.68M | 31.18M |
| Interest income | 49.53M | 43.42M | 30.98M | 27.20M | 23.04M |
| Net interest income | -501.44M | -405.87M | -408.82M | -314.63M | -193.72M |
| Income tax expense | 90.68M | 27.47M | 24.17M | 35.68M | 31.18M |
| Total revenue | 3624.63M | 3304.33M | 2875.91M | 2329.06M | 1719.37M |
| Total operating expenses | 1147.17M | 1076.61M | 999.04M | 805.58M | 629.48M |
| Cost of revenue | 1288.09M | 1215.60M | 1109.81M | 859.55M | 652.30M |
| Total other income expense net | -345.34M | -335.72M | -337.48M | -235.67M | -167.43M |
| Net income from continuing ops | 768.44M | 648.92M | 374.86M | 392.76M | 242.28M |
| Net income applicable to common shares | - | - | - | 373.57M | 223.33M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 9353.24M | 8829.54M | 7584.48M | 7199.54M | 6447.41M |
| Intangible assets | 4059.21M | 4006.06M | 3461.32M | 2784.45M | 2716.50M |
| Other current assets | 62.92M | 57.15M | 58.91M | 51.74M | 42.53M |
| Total liab | 4464.51M | 4518.96M | 3941.47M | 3949.38M | 3447.39M |
| Total stockholder equity | 4849.36M | 4269.95M | 3601.51M | 3198.84M | 2948.15M |
| Other current liab | 485.74M | 565.28M | 226.71M | 199.61M | 184.82M |
| Common stock | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M |
| Capital stock | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M |
| Retained earnings | 2633.23M | 2011.88M | 1380.37M | 1004.89M | 631.32M |
| Other liab | - | - | - | 568.93M | 687.35M |
| Good will | 1525.97M | 1526.73M | 1334.70M | 1257.05M | 1184.34M |
| Other assets | 0.00M | - | - | 234.32M | 207.75M |
| Cash | 1124.82M | 911.01M | 553.03M | 1093.08M | 748.56M |
| Total current liabilities | 883.60M | 1140.19M | 1058.57M | 905.69M | 766.51M |
| Current deferred revenue | 157.96M | - | 153.49M | 133.05M | 114.58M |
| Net debt | 1993.63M | 2262.48M | 2122.31M | 1621.52M | 1413.12M |
| Short term debt | 116.38M | 409.13M | 216.15M | 239.84M | 168.15M |
| Short long term debt | 60.67M | 363.55M | 179.25M | 207.38M | 143.20M |
| Short long term debt total | 3118.45M | 3173.50M | 2675.34M | 2714.60M | 2161.69M |
| Other stockholder equity | 2013.40M | 2070.57M | 2066.05M | 2193.93M | 2316.82M |
| Property plant equipment | - | - | - | 1232.16M | 1083.49M |
| Total current assets | 1941.20M | 1589.78M | 1203.51M | 1637.66M | 1206.85M |
| Long term investments | 46.52M | 54.44M | 51.83M | 53.91M | 48.48M |
| Net tangible assets | - | - | - | -842.65M | -952.69M |
| Net receivables | 753.47M | 621.62M | 590.19M | 480.64M | 403.93M |
| Long term debt | 1993.60M | 1831.61M | 1621.52M | 1737.70M | 1304.40M |
| Inventory | - | - | 1.38M | 12.19M | 11.83M |
| Accounts payable | 123.52M | 128.08M | 462.22M | 333.19M | 298.95M |
| Accumulated other comprehensive income | 202.71M | 187.50M | 155.07M | - | - |
| Non currrent assets other | 137.96M | 151.82M | 117.35M | 234.32M | 180.31M |
| Non current assets total | 7412.04M | 7239.76M | 6380.98M | 5561.88M | 5240.55M |
| Capital lease obligations | 1065.75M | 978.34M | 874.57M | 769.52M | 714.09M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -1091.61M | -1074.53M | -591.47M | -1274.05M |
| Change to liabilities | - | - | - | 18.36M | 50.49M |
| Total cashflows from investing activities | -498.11M | -1091.61M | -1143.05M | -591.47M | -1274.05M |
| Net borrowings | -179.44M | 321.68M | -138.81M | 265.00M | 563.71M |
| Total cash from financing activities | -489.20M | 23.97M | -439.94M | 92.94M | 364.68M |
| Change to operating activities | - | - | - | 7.39M | 1.33M |
| Net income | 737.68M | 676.39M | 429.58M | 428.43M | 273.46M |
| Change in cash | 317.15M | 357.99M | -540.05M | 344.52M | -296.48M |
| Begin period cash flow | 807.66M | 553.03M | 1093.08M | 748.56M | 1045.04M |
| End period cash flow | 1124.82M | 911.01M | 553.03M | 1093.08M | 748.56M |
| Total cash from operating activities | 1199.24M | 1432.66M | 1043.62M | 843.90M | 630.87M |
| Issuance of capital stock | - | - | - | 0.00M | 0.00M |
| Depreciation | 373.34M | 333.34M | 289.51M | 206.22M | 154.22M |
| Other cashflows from investing activities | -0.00M | -327.12M | -117.09M | 6.75M | 8.80M |
| Dividends paid | 0.00M | 0.00M | 0.00M | - | - |
| Change to inventory | - | - | 10.95M | -0.36M | -3.72M |
| Change to account receivables | -184.65M | -79.34M | -131.34M | -129.16M | -79.67M |
| Sale purchase of stock | -75.49M | - | -12.37M | -152.32M | -213.72M |
| Other cashflows from financing activities | -311.46M | -297.71M | -288.76M | 477.15M | 824.23M |
| Change to netincome | - | - | - | 374.03M | 302.12M |
| Capital expenditures | 162.75M | 392.62M | 245.43M | 297.02M | 276.80M |
| Change in working capital | -208.81M | -19.36M | -59.39M | -109.92M | -48.80M |
| Stock based compensation | 15.32M | 32.42M | 31.54M | 31.27M | 43.38M |
| Other non cash items | 670.37M | 409.87M | 352.39M | 287.89M | 175.65M |
| Free cash flow | 1036.49M | 1040.04M | 798.20M | 546.88M | 354.07M |
Sector: Consumer Defensive Industry: Education & Training Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AFYA Afya Ltd |
-0.18 1.68% |
10.55 | 9.61 | 7.13 | 0.39 | 1.47 | 2.47 | 5.46 |
| EDU New Oriental Education & Technology |
-0.36 0.68% |
52.40 | 18.94 | 12.42 | 1.60 | 2.27 | 0.84 | 7.37 |
| NWOEF New Oriental Education & Technology Group Inc. |
- -% |
4.52 | 15.07 | 9.88 | 1.27 | 1.80 | 0.87 | 7.67 |
| TAL TAL Education Group |
-0.01 0.05% |
10.06 | 7.34 | 9.21 | 2.04 | 1.58 | 1.25 | 10.01 |
| LAUR Laureate Education Inc |
-0.07 0.20% |
35.54 | 16.23 | 15.31 | 2.70 | 4.44 | 3.08 | 9.75 |
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy. The Continuing Education segment provides medical education, including residency preparation programs, specialization test preparation, graduate courses in medicine, and digital and in-person professional development for physicians and medical students. The Medical Practice Solutions segment offers clinical decision support platforms, medical practice management software, healthcare financial services, and digital healthcare ecosystem solutions, such as electronic medical records, practice management tools, telemedicine, digital prescriptions, and doctor-patient relationship platforms. This segment also provides a subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. The company also offers educational health and medical imaging; and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. In addition, it offers printed and digital content, as well as an online medical education platform and physicians, healthcare professionals and students. Afya Limited was founded in 1999 and is headquartered in Belo Horizonte, Brazil.
Rua Paraíba, No. 330, Belo Horizonte, MG, Brazil, 30130-917
55 31 3515 7550
9395
| Name | Title | Year Born |
|---|---|---|
| Mr. Virgilio Deloy Capobianco Gibbon | Chief Exec. Officer | 1976 |
| Mr. Luis Andre Carpintero Blanco | Chief Financial Officer | 1973 |
| Renata Couto | Investor Relations Exec. Mang. | NA |
| Mr. Julio Eduardo Razente de Angeli | VP of Continuing Education & Innovation | 1973 |
| Mr. Virgilio Deloy Capobianco Gibbon | Chief Executive Officer | 1976 |
| Renata Couto | Investor Relations Executive Manager | NA |
| Mr. Julio Eduardo Razente de Angeli | Vice President of Continuing Education & Innovation | 1973 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.